Management of transient ischaemic attacks and stroke

Area of Science:

• Neurology
• Vascular Medicine
• Public Health

Background:

• Stroke and transient ischaemic attack (TIA) management has evolved significantly over the past 20 years.
• Blood pressure control is a cornerstone of stroke prevention strategies.
• Established treatments like aspirin, warfarin, and carotid endarterectomy are crucial for specific patient groups.

Purpose of the Study:

• To provide a practical guide for the day-to-day management of patients with cerebrovascular disease.
• To emphasize evidence-based clinical decision-making for stroke and TIA.
• To highlight the benefits of specialized acute stroke unit care.

Main Methods:

• Review of large multicentre trials and established clinical guidelines.
• Emphasis on foundational clinical skills: history taking, physical examination, and appropriate investigations.
• Integration of knowledge regarding natural history, risk factors, and treatment efficacy.

Main Results:

• Multicentre trials confirm the efficacy of aspirin for TIAs, warfarin for atrial fibrillation and embolic events, and carotid endarterectomy for carotid TIAs.
• Patients treated in acute stroke units demonstrate higher rates of independence at six months compared to general medical wards.
• Evidence supports a management approach grounded in clinical assessment and trial data.

Conclusions:

• Optimal management of cerebrovascular disease requires a synthesis of clinical evaluation and evidence from randomized controlled trials.
• Adherence to proven preventive and therapeutic strategies is key to improving patient outcomes.
• Specialized stroke care units enhance functional recovery and independence post-event.